Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-04-03 Sale |
2024-04-05 4:55 pm |
Kinnate Biopharma Inc. | KNTE | Flaherty Keith T. Director |
66,377 | $0 | $0 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-12 Option Award |
2023-06-13 6:28 pm |
N/A 2033-06-12 |
Kinnate Biopharma Inc. | KNTE | Flaherty Keith T. Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-06-13 Option Award |
2022-06-15 5:01 pm |
N/A 2032-06-13 |
Kinnate Biopharma Inc. | KNTE | Flaherty Keith T. Director |
20,250 | $0 | 20,250 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-21 9:24 pm |
N/A 2031-06-16 |
Checkmate Pharmaceuticals Inc. | CMPI | Flaherty Keith T. Director |
10,030 | $0 | 10,030 (Direct) |
View |
| 2021-06-11 Option Award |
2021-06-14 7:13 pm |
N/A 2031-06-11 |
Kinnate Biopharma Inc. | KNTE | Flaherty Keith T. Director |
20,250 | $0 | 20,250 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-11 9:02 pm |
N/A 2031-06-10 |
Clovis Oncology Inc. | CLVS | Flaherty Keith T. Director |
42,223 | $0 | 42,223 (Direct) |
View |
Ownership |
2020-12-02 9:11 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | Flaherty Keith T. Director |
0 | $0 | 165,944 (Direct) |
View |
Ownership |
2020-08-06 9:04 pm |
2020-03-27 2028-03-27 |
Checkmate Pharmaceuticals Inc. | CMPI | Flaherty Keith T. Director |
0 | $0 | 26,748 (Direct) |
View |
| 2020-06-04 Option Award |
2020-06-05 5:03 pm |
N/A 2030-06-04 |
Clovis Oncology Inc. | CLVS | Flaherty Keith T. Director |
40,138 | $0 | 40,138 (Direct) |
View |